Commitments and Contingencies (Tables)

9 Months Ended

12 Months Ended

Mar. 31, 2016

Jun. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments And Contingencies Disclosure [Table Text Block]

Commitments and contingencies are described below and summarized by the following table for the designated fiscal years ending June 30, as of March 31, 2016:

			Remaining
	Total		2016		2017		2018		2019		2020		Thereafter

Management fee	$	901,000	$	53,000	$	212,000	$	212,000	$	212,000	$	212,000	$	-
Primsol business		1,250,000		1,000,000		250,000		-		-		-		-
Manufacturing agreement		1,000,000		1,000,000		-		-		-		-		-
Office Lease		351,000		34,000		142,000		145,000		30,000		-		-
Sponsored research agreement with related party		298,000		18,000		70,000		70,000		70,000		70,000		-
	$	3,800,000	$	2,105,000	$	674,000	$	427,000	$	312,000	$	282,000	$	-

Commitments and contingencies are described below and summarized by the following table as of June 30, 2015:

	Total		2016		2017		2018		2019		2020		Thereafter

Management fee	$	1,800,000	$	360,000	$	360,000	$	360,000	$	360,000	$	360,000	$	—
ProstaScint Inventory Transfer		500,000		500,000		—		—		—		—		—
Sponsored research agreement with related party		350,000		70,000		70,000		70,000		70,000		70,000		—
Clinical research and trial obligations		329,000		329,000		—		—		—		—		—
Manufacturing		133,000		133,000		—		—		—		—		—
Office Lease		110,000		35,000		36,000		36,000		3,000		—		—
	$	3,222,000	$	1,427,000	$	466,000	$	466,000	$	433,000	$	430,000	$	—

Schedule of Rent Expense [Table Text Block]

Rent expense for the respective periods is as follows:

	Three Months Ended March 31,				Nine Months Ended March 31,
	2016		2015		2016		2015

Rent expense	$	35,000	$	3,000	$	86,000	$	43,000

Rent expense for the respective periods is as follows:

	Years Ended June 30,
	2015		2014

Rent expense	$	51,000	$	11,000